Medtronic sensor placement for diabetes

The Guardian Connect System is not intended to make therapy adjustments: always check your capillary blood glucose before making therapy adjustments. Do not ignore alerts from your Guardian Connect System. Always follow your treatment instructions from your Healthcare Professional when responding to an alert from your Guardian Connect System. The MiniMed G system is intended for the management of Type 1 diabetes mellitus in persons age 7 and older requiring insulin. For persons that are 14 years of age and older, sensor placement and insertion has been studied in the belly abdomen and back of upper arm only and is not licensed for other sites.

All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system. Accessed July 31, Upload your data to view reports of averages and trends over periods of up to 90 days.

CGMs are now widespread and widely covered by insurance to benefit both Type 1s and Type 2s. Several manufacturers are getting in on the action, offering a variety of features and costs. We discuss the features of each below. Dexcom Dexcom was one of the first developers of CGM technology. Their latest, the Dexcom G6 , makes monitoring your glucose easy.

Each sensor lasts 10 days. While they are only FDA-approved for placement on the stomach, many users report successfully wearing them on arms and even legs with little or no loss of accuracy. This provides for more flexible arrangements, especially if you also wear a pump. Sensors last 10 days, but resourceful users concerned about keeping costs say they can extend their use.

Katie DiSimone has tips on how to extend their use. This is for the brave of heart, and we have not confirmed their optimism. Each sensor comes pre-loaded in a single-use applicator that applies the sensor to the skin, making insertion easy.

A reusable transmitter then snaps into the sensor. Although the G6 does not require an over-tape, Dexcom offers one that many pumpers use. The transmitter requires no charging and gets replaced every 90 days. The G6 requires no calibration, but you can calibrate if a meter reading differs from that of the CGM. Dexcom earned its no-calibration designation from the FDA because of its consistent accuracy over 10 days. The G6 works with a dedicated receiver, an insulin pump Tandem t:slim or Omnipod , or an app on your smartphone.

A smartwatch can display glucose readings for quick viewing. With the Clarity app , the G6 automatically loads data to it, and from which you can later generate reports for yourself or your healthcare team. The G7 combines the sensor and transmitter into a single unit that gets replaced every 10 and perhaps every 14 days. We expect it to improve accuracy and have a slimmer profile, a smaller application device, and lower cost. Dexcom is working to launch the G7 by the end of and hopes to have cell phone connectivity early in

Sorry, clippers team store assured

Clean your chosen site with an alcohol swab and allow the alcohol to dry. Do not use IV prep. Check to see that the Oval Tape is applied correctly. Check your site regularly and apply additional off-the-shelf tape if sensor and transmitter are not secure.

Starting the Sensor After inserting and taping your sensor, return to your Guardian Connect app on your mobile device to complete the sensor start up. Tap Start New Sensor. When the sensor has connected, you will see a message reminding you that the warm up may take up to 2 hours. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional.

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts.

Both systems require a prescription. Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy.

Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected.

The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a result taken from an Alternative Site palm or a result from a control solution test.

Under some conditions of use the pump can suspend again, resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia. See www.